Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters

Prognosis of HPV negative head and neck squamous cell carcinoma (HNSCC) patients remains poor despite surgical and medical advances and inadequacy of predictive and prognostic biomarkers in this type of cancer highlights one of the challenges to successful therapy. Statins, widely used for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehibel, Manal, Ortiz-Martinez, Fernando, Voelxen, Nadine, Boyers, Amy, Chadwick, Amy, Telfer, Brian A., Mueller-Klieser, Wolfgang, West, Catharine M., Critchlow, Susan E., Williams, Kaye J., Stratford, Ian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235971/
https://www.ncbi.nlm.nih.gov/pubmed/30429503
http://dx.doi.org/10.1038/s41598-018-35103-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235971/
https://www.ncbi.nlm.nih.gov/pubmed/30429503
http://dx.doi.org/10.1038/s41598-018-35103-1

Ejemplares similares